Arglemane Pty. Limited

Status: Registered
Australian Company Number: 065635743
Australian Business Number: 97065635743
Registration date: 1994/07/12
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Arglemane Pty Limited is a limited by shares, Australian proprietary company. This corporation was registered on 1994-07-12 and was issued with the 065635743 ACN. Its Australian Business Number is 97065635743. Since 2000-03-15, the company is headquartered in NSW, post code 2264. Arglemane Pty Limited was registered for the GST on 2000-07-01. Arglemane Pty Limited has been using the Arglemane P/l trading name since 2000-03-15 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2000-07-01. We found 0 trademarks that mention this company.


Details for ABN 97065635743

Type: Australian Private Company

ABN Status

Status From To
Active 2000/03/15 current

Main Name

Name From To
Arglemane Pty. Limited 2000/06/05 current
Arglemane Pty Ltd 2000/03/15 2000/06/05

Trading Names

Name From To
Arglemane P/l 2000/03/15 current

Main Location

Location From To
NSW 2264 2000/03/15 current

Goods & Services Tax (GST)

Status From To
Registered 2000/07/01 current


Find company

NSW 2264 Location

2016 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (, and, ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.